The FDA has dropped its complaint against fitness tracker company Whoop over its blood pressure monitoring feature, reversing its earlier demand that the tool be disabled.
The reversal marks a significant shift in the agency's regulatory stance toward Whoop's wearable device. The FDA initially took issue with the blood pressure tracking capability, viewing it as a medical device requiring regulatory clearance.
Whoop's blood pressure tool allows users to monitor cardiovascular health through its wrist-worn tracker. The feature had drawn FDA scrutiny over classification and approval pathways, leading to the agency's initial complaint.
The withdrawal suggests either a resolution between Whoop and the FDA regarding the tool's claims and functionality, or a reassessment by the agency of how consumer health tracking features should be regulated.
This outcome could have implications for other wearable manufacturers offering similar health monitoring capabilities. The fitness tracker market continues to expand its health-focused features, creating ongoing questions about where regulators draw lines between consumer wellness tools and medical devices.
Whoop has not yet publicly commented on the FDA's decision.
Google is rolling out new features to its Pixel Buds Pro 2 and 2a models, with deeper integration of its Gemini AI assistant. No new hardware was released this year.
Northrop Grumman's Mission Robotic Vehicle is attempting to attach a new thruster to an aging satellite, marking the first real-world test of on-orbit satellite servicing technology.
A widespread outage affecting Petlibro's smart pet devices has prevented scheduled feeding since Tuesday. Users report their smart feeders, litter boxes, and water fountains have gone offline despite company claims that local settings should continue operating.
Insta360 unveiled the X6, its latest 360-degree action camera featuring larger sensors and faster frame rates in a more compact body than previous models.